Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke - Schneider, D; Berrouschot, J; Brandt, T (Eur Neurol, 1998)